Collectively, these results suggested that c-Myc regulated the HIF-1α/SDF-1/CXCR4 pathway in pancreatic cancer cells to enhance the antitumor effect of bufalin. The gene discussed is CXCR4; the disease is familial pancreatic carcinoma.